Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.

News

Awards
SIRS Early Career Award
Publications
How to Run Behavioural Experiments Online: Best Practice Suggestions for Cognitive Psychology and Neuroscience
Publications
Psychedelics in Psychiatry – Development and Current State in Germany
Publications
Ketamine as a Treatment Option for Severe Borderline Personality Disorder: A Case Report
Awards
Highly Cited Researcher 2022 Honour for Prof. Borgwardt
Publications
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium
01/03

Mission

We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.

02/03

About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.

03/03

Research

Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top